These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16566446)

  • 1. Basis for sample size in international conference on harmonization guidances.
    Lubiniecki A
    Dev Biol (Basel); 2006; 123():201-5; discussion 217-22. PubMed ID: 16566446
    [No Abstract]   [Full Text] [Related]  

  • 2. Insect cells as a new substrate for vaccine production.
    Dalemans W
    Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues related to harmonization of testing requirements for viral safety.
    Hayakawa T
    Dev Biol Stand; 1996; 88():15-8. PubMed ID: 9119129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer molecular approaches to detect known viruses and previously unrecognized viruses in cell substrates.
    Wright RF
    Dev Biol (Basel); 2006; 123():177-80; discussion 183-97. PubMed ID: 16566445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine cell substrates: bovine and porcine virus considerations.
    Wessman SJ
    Dev Biol (Basel); 2006; 123():273-80; discussion 291-308. PubMed ID: 16566453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment of Madin Darby canine kidney cells as vaccine substrate.
    Medema JK; Meijer J; Kersten AJ; Horton R
    Dev Biol (Basel); 2006; 123():243-50; discussion 265-6. PubMed ID: 16566450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventitious agent test methods.
    Sheets RL
    Dev Biol (Basel); 2006; 123():135-45; discussion 183-97. PubMed ID: 16566441
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal-free culture process for manufacture of viral vaccines: process validation and regulatory perspectives.
    Pierard I; Mareschal JC; Gonze MM; Duchêne M
    Dev Biol (Basel); 2006; 123():283-90; discussion 291-308. PubMed ID: 16566454
    [No Abstract]   [Full Text] [Related]  

  • 9. Scope and practicality of in vivo testing for adventitious agents.
    Whiteman MD
    Dev Biol (Basel); 2006; 123():147-52; discussion 183-97. PubMed ID: 16566442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: High temperature short time treatment of cell culture media and feed solutions to mitigate adventitious viral contamination in the biopharmaceutical industry.
    Djemal L; Fournier C; von Hagen J; Kolmar H; Deparis V
    Biotechnol Prog; 2021 May; 37(3):e3117. PubMed ID: 33372404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of OIE in harmonization.
    Roth JA
    Dev Biol (Basel); 2004; 119():377-9. PubMed ID: 15742649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-contamination of cell lines in culture.
    Bubeník J
    Folia Biol (Praha); 2000; 46(5):163-4. PubMed ID: 11055793
    [No Abstract]   [Full Text] [Related]  

  • 13. Detecting viruses in sera: methods used and their merits.
    Jennings A
    Dev Biol Stand; 1999; 99():51-9. PubMed ID: 10404876
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality control of bovine serum used for vaccine production.
    Mareschal JC
    Dev Biol Stand; 1999; 99():61-8. PubMed ID: 10404877
    [No Abstract]   [Full Text] [Related]  

  • 15. SQA opinion paper on global harmonization of the bioanalytical method validation guidances.
    Tudan C; Rogenthien S; Jones A
    Bioanalysis; 2010 Dec; 2(12):1921-5. PubMed ID: 21110735
    [No Abstract]   [Full Text] [Related]  

  • 16. [Culture media for sterility testing. Comparison of the regulations of the pharmacopoeia of the GDR with other pharmacopoeias].
    Friedemann J
    Z Gesamte Hyg; 1980; 26(12):908-13. PubMed ID: 7234011
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.
    Castle P; Robertson JS
    Dev Biol Stand; 1999; 99():191-6. PubMed ID: 10404890
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():177-201. PubMed ID: 9737396
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral safety of biological products and the concept of validation.
    Horaud F
    Dev Biol Stand; 1996; 88():19-24. PubMed ID: 9119135
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.